HAEMONETICS CORP/MASS (HAE) Stock Price & Overview

NYSE:HAE • US4050241003

Current stock price

58.46 USD
-0.12 (-0.2%)
At close:
58.46 USD
0 (0%)
After Hours:

The current stock price of HAE is 58.46 USD. Today HAE is down by -0.2%. In the past month the price decreased by -4.62%. In the past year, price decreased by -7.49%.

HAE Key Statistics

52-Week Range47.315 - 87.32
Current HAE stock price positioned within its 52-week range.
1-Month Range57.96 - 66.09
Current HAE stock price positioned within its 1-month range.
Market Cap
2.717B
P/E
11.88
Fwd P/E
10.88
EPS (TTM)
4.92
Dividend Yield
N/A

HAE Stock Performance

Today
-0.2%
1 Week
-2.08%
1 Month
-4.62%
3 Months
-27.18%
Longer-term
6 Months +21.36%
1 Year -7.49%
2 Years -31.51%
3 Years -29.35%
5 Years -47.34%
10 Years +67.12%

HAE Stock Chart

HAEMONETICS CORP/MASS / HAE Daily stock chart

HAE Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to HAE. When comparing the yearly performance of all stocks, HAE is a bad performer in the overall market: 82.46% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

HAE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to HAE. HAE scores excellent on profitability, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HAE Earnings

On February 5, 2026 HAE reported an EPS of 1.31 and a revenue of 338.97M. The company beat EPS expectations (3.75% surprise) and beat revenue expectations (1.21% surprise).

Next Earnings DateMay 6, 2026
Last Earnings DateFeb 5, 2026
PeriodQ3 / 2026
EPS Reported$1.31
Revenue Reported338.967M
EPS Surprise 3.75%
Revenue Surprise 1.21%

HAE Forecast & Estimates

15 analysts have analysed HAE and the average price target is 89.76 USD. This implies a price increase of 53.54% is expected in the next year compared to the current price of 58.46.

For the next year, analysts expect an EPS growth of 9.31% and a revenue growth -2.55% for HAE


Analysts
Analysts78.67
Price Target89.76 (53.54%)
EPS Next Y9.31%
Revenue Next Year-2.55%

HAE Groups

Sector & Classification

HAE Financial Highlights

Over the last trailing twelve months HAE reported a non-GAAP Earnings per Share(EPS) of 4.92. The EPS increased by 16.31% compared to the year before.


Income Statements
Revenue(TTM)1.32B
Net Income(TTM)175.44M
Industry RankSector Rank
PM (TTM) 13.31%
ROA 7.04%
ROE 19.25%
Debt/Equity 1.01
Chartmill High Growth Momentum
EPS Q2Q%10.08%
Sales Q2Q%-2.75%
EPS 1Y (TTM)16.31%
Revenue 1Y (TTM)-4.02%

HAE Ownership

Ownership
Inst Owners112.31%
Shares46.47M
Float45.92M
Ins Owners1.18%
Short Float %5.93%
Short Ratio3.05

About HAE

Company Profile

HAE logo image The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees.

Company Info

IPO: 1979-10-17

HAEMONETICS CORP/MASS

125 Summer Street

Boston MASSACHUSETTS 02110 US

CEO: Christopher A. Simon

Employees: 3023

HAE Company Website

HAE Investor Relations

Phone: 17818487100

HAEMONETICS CORP/MASS / HAE FAQ

What does HAEMONETICS CORP/MASS do?

The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees.


Can you provide the latest stock price for HAEMONETICS CORP/MASS?

The current stock price of HAE is 58.46 USD. The price decreased by -0.2% in the last trading session.


Does HAE stock pay dividends?

HAE does not pay a dividend.


What is the ChartMill technical and fundamental rating of HAE stock?

HAE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


How is the valuation of HAEMONETICS CORP/MASS (HAE) based on its PE ratio?

The PE ratio for HAEMONETICS CORP/MASS (HAE) is 11.88. This is based on the reported non-GAAP earnings per share of 4.92 and the current share price of 58.46 USD.


How many employees does HAEMONETICS CORP/MASS have?

HAEMONETICS CORP/MASS (HAE) currently has 3023 employees.


What is the next earnings date for HAE stock?

HAEMONETICS CORP/MASS (HAE) will report earnings on 2026-05-06, after the market close.